CardioMEMS, the real progress in heart failure home monitoring

  • Edoardo GrondaEmail author
  • Emilio Vanoli
  • Alessandro Zorzi
  • Domenico Corrado


The burden of hospitalizations driven by exacerbation of acute heart failure remains unacceptably high. The associated use of hospital resources drives increasing patient, caregiver, and economic costs. Noninvasive telemedical systems investigated in randomized controlled trials have failed to demonstrate to reduce hospitalization rates probably because of the indirect (non-linear) relationship of the measured biological signals with the patient congestion status. Instead, there is increasing evidence that direct measure of intracardiac and pulmonary artery pressure can effectively guide heart failure management and reduce hospitalizations. Early studies adopting implantable hemodynamic monitors in the right heart unveiled the potential of pressure-based heart failure management, whereas subsequent investigations showed the powerful preemptive approach for heart failure exacerbations. One large randomized trial (CHAMPION) proved that a direct pulmonary pressure monitor system (CardioMEMS) substantially reduced heart failure hospitalizations in subjects randomized to active pulmonary pressure-guided management. The system monitoring safety and efficacy were also excellent. The study proved that early management in response to increased pulmonary pressure is able to provide the most effective therapeutic intervention to prevent heart failure exacerbations.


Heart failure Hemodynamics Monitoring Treatment Sympathetic system Clinical studies 



  1. 1.
    Lee DS, Austin PC, Stukel TA et al (2009) “Dosedependent” impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med 122:162–9.e1CrossRefGoogle Scholar
  2. 2.
    O’Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M (2005) Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Cardiac Fail 11:200–205CrossRefGoogle Scholar
  3. 3.
    Wong YW, Fonarow GC, Mi X, Peacock WF 4th, Mills RM, Curtis LH, Qualls LG, Hernandez AF (2013) Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). Am Heart J 166(2):349–356. CrossRefGoogle Scholar
  4. 4.
    Roberts E, Ludman AJ, Dworzynski K, al-Mohammad A, Cowie MR, McMurray JJV, Mant J, for the NICE Guideline Development Group for Acute Heart Failure (2015) The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ 350:h910CrossRefGoogle Scholar
  5. 5.
    Davenport C, Cheng EY, Kwok YT et al (2006) Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis. Br J Gen Pract 56:48–56Google Scholar
  6. 6.
    Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM (2010) Telemonitoring in patients with heart failure [Published corrections appear in N Engl J Med 2011;364:490 and N Engl J Med 2013;369:1869]. N Engl J Med 363:2301–2309CrossRefGoogle Scholar
  7. 7.
    Setoguchi S, Stevenson LW, Schneeweiss S (2007) Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 154:260–266CrossRefGoogle Scholar
  8. 8.
    Yancy C, Abraham WT (2004) Congest Heart Fail. 2003 Sep-Oct;9(5):241–50. Erratum in: Noninvasive hemodynamic monitoring in heart failure: utilization of impedancecardiography. Congest Heart Fail 10(3):139Google Scholar
  9. 9.
    Koehler F, Winkler S, Schieber M et al (2011) Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: Telemedical interventional monitoring in heart failure study. Circulation 123:1873–1880CrossRefGoogle Scholar
  10. 10.
    Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW, for the COMPASS-HF Study Group (2008) Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 51:1073–1079CrossRefGoogle Scholar
  11. 11.
    Adamson PB (2011) Pathophysiology of the transition from chronic compensated to acute decompensated heart failure: new insights from continuous monitoring devices. J Card Fail 17:3–10CrossRefGoogle Scholar
  12. 12.
    Abraham WT, Adamson PB, Hasan A, Bourge RC, Pamboukian SV, Aaron MF, Raval NY (2011) Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. Am Heart J 161:558–566CrossRefGoogle Scholar
  13. 13.
    Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS, for the CHAMPION Trial Study Group (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377:658–666CrossRefGoogle Scholar
  14. 14.
    Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, Henderson J, Cowart P, Stevenson LW (2014) Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail 7:935–944CrossRefGoogle Scholar
  15. 15.
    Benza RL, Raina A, Abraham WT, Adamson PB, Lindenfeld JA, Miller AB, Bourge RC, Bauman J, Yadav J (2015) Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor. J Heart Lung Transplant 34:329–337CrossRefGoogle Scholar
  16. 16.
    Krahnke JS, Abraham WT, Adamson PB, Bourge RC, Bauman J, Ginn G, Martinez FJ, Criner GJ, Champion Trial Study Group (2015) Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. J Card Fail 21:240–249CrossRefGoogle Scholar
  17. 17.
    Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB, for the CHAMPION Trial Study Group (2016) Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomized trial. Lancet 387:453–461CrossRefGoogle Scholar
  18. 18.
    Costanzo MR, Stevenson LW, Adamson PB et al (2016) Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. J Am Coll Cardiol HF 4:333–344Google Scholar
  19. 19.
    Heywood JT, Jermyn R, Shavelle D, Abraham WT, Bhimaraj A, Bhatt K, Sheikh F, Eichorn E, Lamba S, Bharmi R, Agarwal R, Kumar C, Stevenson LW (2017) Impact of practice-based management of pulmonary artery pressures in 2000 patients implanted with the CardioMEMS sensor. Circulation 135:1509–1517CrossRefGoogle Scholar
  20. 20.
    Krumholz HM, Dhruva SS (2017) Real-world data on heart failure readmission reduction. Real or real uncertain? J Am Coll Cardiol 69(19):2366–2368. CrossRefGoogle Scholar
  21. 21.
    Linde RJ (1979) Atrial reflex and renal function. Am J Cardiol 44:879–883CrossRefGoogle Scholar
  22. 22.
    Dibner-Dunlap ME, Thames MD (1992) Control of sympathetic nerve activity by vagal mechanoreflexes is blunted in heart failure. Circulation 86:1929–1934CrossRefGoogle Scholar
  23. 23.
    Volpe M, Magri P, Rao MA, Cangianiello S, DeNicola L, Mele AF, Memoli B, Enea I, Rubattu S, Gigante B, Trimarco B, Epstein M, Condorelli M (1997) Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition. Hypertension 30(2 Pt 1):168–176CrossRefGoogle Scholar
  24. 24.
    Moore JP, Hainsworth R, Drinkhill MJ (2004) Phasic negative intrathoracic pressures enhance the vascular responses to stimulation of pulmonary arterial baroreceptors in closed-chest anaesthetized dogs. J Physiol 555:815–824CrossRefGoogle Scholar
  25. 25.
    Stevenson LW, Zile M, Bennett TD, Kueffer FJ, Jessup ML, Adamson P, Abraham WT, Manda V, Bourge RC (2010) Chronic ambulatory intracardiac pressures and future heart failure events. Circ Heart Fail 3(5):580–587. CrossRefGoogle Scholar
  26. 26.
    Burchell AE, Sobotka PA, Hart EC, Nightingale AK, Dunlap ME (2013) Chemohypersensitivity and autonomic modulation of venous capacitance in the pathophysiology of acute decompensated heart failure. Curr Heart Fail Rep 10:139–146CrossRefGoogle Scholar
  27. 27.
    Nijst P, Verbrugge FH, Martens P, Dupont M, Tang WHW, Mullens W (2017) Plasma volume is normal but heterogeneously distributed, and true anemia is highly prevalent in patients with stable heart failure. Int J Cardiol 243:318–325. CrossRefGoogle Scholar
  28. 28.
    Jenkins BS, Bradley RD, Branthwaite MA. Evaluation of pulmonary arterial end-diastolic pressure as an indirect estimate of left atrial mean pressure. Circulation 1970;42:75–8.
  29. 29.
    Drazner MH, Hamilton MA, Fonarow G, Creaser J, Flavell C, Stevenson LW. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. Drazner MH, Hamilton MA, Fonarow G, Creaser J, Flavell C, Stevenson LW. J Heart Lung Transplant. 1999 Nov 18(11):1126–32Google Scholar
  30. 30.
    Abraham WT, Adamson PB, Costanzo MR, Eigler N, Gold M, Klapholz M, Maurer M, Saxon L, Singh J, Troughton R (2016) Hemodynamic monitoring in advanced heart failure: results from the LAPTOP-HF trial [abstr]. J Card Fail 22:940CrossRefGoogle Scholar
  31. 31.
    Drazner MH, Velez-Martinez M, Ayers CR, Reimold SC, Thibodeau JT, Mishkin JD, Mammen PP, Markham DW, Patel CB Relationship of Rightto Left-Sided Ventricular Filling Pressures in Advanced Heart Failure Insights From the ESCAPE Trial, Circulation: Heart Failure. 2013;6:264–270.
  32. 32.
    Testani JM, Hanberg JS, Cheng S et al Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure. Circ Heart Fail 8(4):741–748.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico di Milano UOC di Nefrologia, Dialisi e Trapianto Renale dell’adulto Dipartimento Di Medicina e Specialità MedicheMilanItaly
  2. 2.Department of Molecular MedicineUniversity of PaviaPaviaItaly
  3. 3.Cardiovascular DepartmentIRCCS MultiMedicaMilanItaly
  4. 4.Department of Cardiac Thoracic, Vascular Sciences and Public HealthUniversity of PadovaPadovaItaly

Personalised recommendations